Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 581985, 8 pages
http://dx.doi.org/10.1155/2014/581985
Research Article

Antimicrobial Activity of Coronarin D and Its Synergistic Potential with Antibiotics

1Laboratory of Organic Synthesis, Chulabhorn Research Institute, Vibhavadi-Rangsit Highway, Laksi, Bangkok 10210, Thailand
2Laboratory of Natural Products, Chulabhorn Research Institute, Vibhavadi-Rangsit Highway, Laksi, Bangkok 10210, Thailand
3Department of Chemistry and Center of Excellence for Innovation in Chemistry, Faculty of Science, Kasetsart University, Bangkok 10900, Thailand

Received 4 February 2014; Accepted 29 April 2014; Published 15 May 2014

Academic Editor: Marc Léone

Copyright © 2014 Nanthawan Reuk-ngam et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. T. Jamison, J. G. Breman, A. R. Measham et al., Disease Control Priorities in Developing Countries, World Bank, Washington, DC, USA, 2006.
  2. G. S. Leoung and J. Mills, Opportunistic Infections in Patients with the Acquired Immunodeficiency Syndrome, Marcel Dekker, New York, NY, USA, 1989.
  3. K. Inweregbu, J. Dave, and A. Pittard, “Nosocomial infections,” Continuing Education in Anaesthesia, Critical Care and Pain, vol. 5, no. 1, pp. 14–17, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. 2013, http://www.cdc.gov/hai/organisms/pseudomonas.html.
  5. D. Mack, A. P. Davies, L. G. Harris, H. Rohde, M. A. Horstkotte, and J. K.-M. Knobloch, “Microbial interactions in Staphylococcus epidermidis biofilms,” Analytical and Bioanalytical Chemistry, vol. 387, no. 2, pp. 399–408, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. A. K. Person, S. M. Chudgar, B. L. Norton, B. C. Tong, and J. E. Stout, “Aspergillus niger: an unusual cause of invasive pulmonary aspergillosis,” Journal of Medical Microbiology, vol. 59, no. 7, pp. 834–838, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. B. Coburn, G. A. Grassl, and B. B. Finlay, “Salmonella, the host and disease: a brief review,” Immunology and Cell Biology, vol. 85, no. 2, pp. 112–118, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. K. J. Ryan and C. G. Ray, Sherris Medical Microbiology, McGraw-Hill, New York, NY, USA, 4th edition, 2004.
  9. B. B. Mishra and V. K. Tiwari, “Natural products: an evolving role in future drug discovery,” European Journal of Medicinal Chemistry, vol. 46, no. 10, pp. 4769–4807, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. N. Chimnoi, C. Sarasuk, N. Khunnawutmanotham et al., “Phytochemical reinvestigation of labdane-type diterpenes and their cytotoxicity from the rhizomes of Hedychium coronarium,” Phytochemistry Letters, vol. 2, no. 4, pp. 184–187, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. N. Chimnoi, S. Pisutjaroenpong, L. Ngiwsara et al., “Labdane diterpenes from the rhizomes of Hedychium coronarium,” Natural Product Research, vol. 22, no. 14, pp. 1255–1262, 2008. View at Google Scholar · View at Scopus
  12. A. B. Kunnumakkara, H. Ichikawa, P. Anand et al., “Coronarin D, a labdane diterpene, inhibits both constitutive and inducible nuclear factor-κB pathway activation, leading to potentiation of apoptosis, inhibition of invasion, and suppression of osteoclastogenesis,” Molecular Cancer Therapeutics, vol. 7, no. 10, pp. 3306–3317, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Kaomongkolgit, K. Jamdee, S. Wongnoi, N. Chimnoi, and S. Techasakul, “Antifungal activity of coronarin D against Candida albicans,” Oral Surgery Oral Medicine Oral Pathology Oral Radiology, vol. 114, no. 1, pp. 61–66, 2012. View at Google Scholar
  14. H. F. Chambers, “General principles of antimicrobial therapy,” in Goodman and Gilman’s Pharmacologiced Basis of Therapeutics, L. L. Bruton, Ed., pp. 1102–1104, McGraw-Hill, New York, NY, USA, 2006. View at Google Scholar
  15. W.-H. Zhao, Z.-Q. Hu, Y. Hara, and T. Shimamura, “Inhibition of penicillinase by epigallocatechin gallate resulting in restoration of antibacterial activity of penicillin against penicillinase-producing Staphylococcus aureus,” Antimicrobial Agents and Chemotherapy, vol. 46, no. 7, pp. 2266–2268, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Oluwatuyi, G. W. Kaatz, and S. Gibbons, “Antibacterial and resistance modifying activity of Rosmarinus officinalis,” Phytochemistry, vol. 65, no. 24, pp. 3249–3254, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. I. X. Liu, D. G. Durham, and R. M. E. Richards, “Baicalin synergy with β-lactam antibiotics against methicillin-resistant Staphylococcus aureus and other β-lactam-resistant strains of S. aureus,” Journal of Pharmacy and Pharmacology, vol. 52, no. 3, pp. 361–366, 2000. View at Google Scholar · View at Scopus
  18. National Committee for Clinical Laboratory Standard, Reference Method for Broth Dilution Antifungal Susceptibility Testing of Conidium-Forming Filamentous Fungi Proposed Standard M38-P, Wayne, Pa, USA, 1998.
  19. Clinical and Laboratory Standards Institute, Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts, Approved Standard-Third Edition, CLSI Document M27-A3, Wayne, Pa, USA, 2008.
  20. National Committee for Clinical Laboratory Standard, Method for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically Approved Standard, M7-A6, Wayne, Pa, USA, 2003.
  21. G. L. French, “Bactericidal agents in the treatment of MRSA infections—the potential role of daptomycin,” Journal of Antimicrobial Chemotherapy, vol. 58, no. 6, pp. 1107–1117, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Bajaksouzian, M. A. Visalli, M. R. Jacobs, and P. C. Appelbaum, “Activities of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with amikacin, against acinetobacters as determined by checkerboard and time-kill studies,” Antimicrobial Agents and Chemotherapy, vol. 41, no. 5, pp. 1073–1076, 1997. View at Google Scholar
  23. N. Didry, L. Dubreuil, and M. Pinkas, “Microbiological properties of protoanemonin isolated from Ranunculus bulbosus,” Phytotherapy Research, vol. 7, no. 1, pp. 21–24, 1993. View at Publisher · View at Google Scholar · View at Scopus
  24. F. Tian, B. Li, B. Ji et al., “Antioxidant and antimicrobial activities of consecutive extracts from Galla chinensis: the polarity affects the bioactivities,” Food Chemistry, vol. 113, no. 1, pp. 173–179, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. J. L. Ríos and M. C. Recio, “Medicinal plants and antimicrobial activity,” Journal of Ethnopharmacology, vol. 100, no. 1-2, pp. 80–84, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Gibbons, “Phytochemicals for bacterial resistance—strengths, weaknesses and opportunities,” Planta Medica, vol. 74, no. 6, pp. 594–602, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Hemaiswarya, A. K. Kruthiventi, and M. Doble, “Synergism between natural products and antibiotics against infectious diseases,” Phytomedicine, vol. 15, no. 8, pp. 639–652, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Urzúa, M. C. Rezende, C. Mascayano, and L. Vásquez, “A structure-activity study of antibacterial diterpenoids,” Molecules, vol. 13, no. 4, pp. 882–891, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. T. S. Porto, R. Rangel, N. A. J. C. Furtado et al., “Pimarane-type diterpenes: antimicrobial activity against oral pathogens,” Molecules, vol. 14, no. 1, pp. 191–199, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. T. C. Carvalho, M. R. Simão, S. R. Ambrósio et al., “Antimicrobial activity of diterpenes from Viguiera arenaria against endodontic bacteria,” Molecules, vol. 16, no. 1, pp. 543–551, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. J. C. Pommerville, Alcamo’s Fundamentals of Microbiology: Body Systems, Jones & Bartlett, LLC, Sudbury, Mass, USA, 2012.
  32. A. Bernabeu, S. Shapiro, and J. Villalaín, “A MAS-NMR study of the location of (+)-totarol, a diterpenoid bioactive molecule, in phospholipid model membranes,” Chemistry and Physics of Lipids, vol. 119, no. 1-2, pp. 33–39, 2002. View at Publisher · View at Google Scholar · View at Scopus
  33. V. Micol, C. R. Mateo, S. Shapiro, F. J. Aranda, and J. Villalaín, “Effects of (+)-totarol, a diterpenoid antibacterial agent, on phospholipid model membranes,” Biochimica et Biophysica Acta—Biomembranes, vol. 1511, no. 2, pp. 281–290, 2001. View at Publisher · View at Google Scholar · View at Scopus
  34. C. R. Mateo, M. Prieto, V. Micol, S. Shapiro, and J. Villalaín, “A fluorescence study of the interaction and location of (+)-totarol, a diterpenoid bioactive molecule, in model membranes,” Biochimica et Biophysica Acta—Biomembranes, vol. 1509, no. 1-2, pp. 167–175, 2000. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Villalaín, “Location of the toxic molecule abietic acid in model membranes by MAS-NMR,” Biochimica et Biophysica Acta, vol. 1328, no. 2, pp. 281–289, 1997. View at Google Scholar
  36. F. J. Aranda and J. Villalaín, “The interaction of abietic acid with phospholipid membranes,” Biochimica et Biophysica Acta, vol. 1327, no. 2, pp. 171–180, 1997. View at Google Scholar
  37. S. Ghosh, K. Indukuri, S. Bondalapati, A. K. Saikia, and L. Rangan, “Unveiling the mode of action of antibacterial labdane diterpenes from Alpinia nigra (Gaertn.) B. L. Burtt seeds,” European Journal of Medicinal Chemistry, vol. 66, pp. 101–105, 2013. View at Google Scholar